Belpointe Asset Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,827
| Closed | -$107K | – | 1880 |
|
|
2023
Q1 | $107K | Sell |
1,827
-294
| -14% | -$17.2K | 0.01% | 1266 |
|
|
2022
Q4 | $132K | Sell |
2,121
-378
| -15% | -$23.5K | 0.01% | 1094 |
|
|
2022
Q3 | $141K | Buy |
2,499
+6
| +0.2% | +$339 | 0.01% | 987 |
|
|
2022
Q2 | $159K | Sell |
2,493
-1,914
| -43% | -$122K | 0.01% | 914 |
|
|
2022
Q1 | $285K | Sell |
4,407
-141
| -3% | -$9.12K | 0.02% | 752 |
|
|
2021
Q4 | $303K | Sell |
4,548
-156
| -3% | -$10.4K | 0.02% | 704 |
|
|
2021
Q3 | $287K | Buy |
4,704
+186
| +4% | +$11.3K | 0.02% | 701 |
|
|
2021
Q2 | $280K | Buy |
4,518
+15
| +0.3% | +$930 | 0.02% | 698 |
|
|
2021
Q1 | $267K | Sell |
4,503
-588
| -12% | -$34.9K | 0.02% | 631 |
|
|
2020
Q4 | $305K | Buy |
5,091
+3,264
| +179% | +$196K | 0.03% | 551 |
|
|
2020
Q3 | $100K | Buy |
+1,827
| New | +$100K | 0.01% | 773 |
|